Patrick Thornton

Ibrutinib versus Ofatumumab in Previously Treated Chronic Lymphoid Leukemia

John C. Byrd, Jennifer R. Brown, Susan O’Brien et al. · New England Journal of Medicine · 2014 · 1.6K citations · Full text

Medicine, Hematology, Oncology +17

First-Line Venetoclax Combinations in Chronic Lymphocytic Leukemia

Barbara Eichhorst, Carsten Utoft Niemann, Arnon P. Kater et al. · New England Journal of Medicine · 2023 · 291 citations · Full text

Medicine, Hematology, Oncology +16

Long-term follow-up of the RESONATE phase 3 trial of ibrutinib vs ofatumumab

John C. Byrd, Peter Hillmen, Susan O’Brien et al. · Blood · 2019 · 243 citations · Full text

Medicine, Immunology, Oncology +8

Extended follow-up and impact of high-risk prognostic factors from the phase 3 RESONATE study in patients with previously treated CLL/SLL

Jennifer R. Brown, Peter Hillmen, Stephen J. O’Brien et al. · Leukemia · 2017 · 238 citations · Full text

Medicine, Hematology, Oncology +11

Treatment of T-cell prolymphocytic leukemia with human CD52 antibody.

Rachel Pawson, Martin J.S. Dyer, R M Y Barge et al. · Journal of Clinical Oncology · 1997 · 210 citations

Medicine, Hematology, Oncology +17